AU5775398A - Site-specific controlled release dosage formulation for mesalamine - Google Patents

Site-specific controlled release dosage formulation for mesalamine

Info

Publication number
AU5775398A
AU5775398A AU57753/98A AU5775398A AU5775398A AU 5775398 A AU5775398 A AU 5775398A AU 57753/98 A AU57753/98 A AU 57753/98A AU 5775398 A AU5775398 A AU 5775398A AU 5775398 A AU5775398 A AU 5775398A
Authority
AU
Australia
Prior art keywords
mesalamine
site
controlled release
release dosage
dosage formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57753/98A
Inventor
Cesare Busetti
Tiziano Crimella
Vincenzo Olgiati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of AU5775398A publication Critical patent/AU5775398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
AU57753/98A 1996-12-17 1997-12-16 Site-specific controlled release dosage formulation for mesalamine Abandoned AU5775398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76798096A 1996-12-17 1996-12-17
US08767980 1996-12-17
PCT/IB1997/001652 WO1998026767A2 (en) 1996-12-17 1997-12-16 Site-specific controlled release dosage formulation for mesalamine

Publications (1)

Publication Number Publication Date
AU5775398A true AU5775398A (en) 1998-07-15

Family

ID=25081155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57753/98A Abandoned AU5775398A (en) 1996-12-17 1997-12-16 Site-specific controlled release dosage formulation for mesalamine

Country Status (2)

Country Link
AU (1) AU5775398A (en)
WO (1) WO1998026767A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
ITMI991316A1 (en) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE
EP1210071A1 (en) * 1999-09-06 2002-06-05 Günther Beisel Method for improving and maintaining bowel function as well as a method for the production thereof
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
EP1615619A2 (en) 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
JP2011500552A (en) * 2007-10-10 2011-01-06 ルピン・リミテッド Pharmaceutical combinations and compositions for treating gastrointestinal disorders
US20110311631A1 (en) * 2009-03-18 2011-12-22 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
US9463163B2 (en) * 2009-10-16 2016-10-11 Sun Pharmaceutical Industries Limited Delayed release pharmaceutical composition of mesalamine
EP2425826A1 (en) * 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
US20140105956A1 (en) * 2012-10-11 2014-04-17 Rupak BANERJEE Biodegradable polymer based microimplant for ocular drug delivery
IN2014MU00097A (en) * 2014-01-10 2015-08-21 Cadila Healthcare Ltd
TR201722039A2 (en) * 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE
EP3662895A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG A process for manufacturing reducing sugar-free 5-asa tablet cores
IT201900018041A1 (en) 2019-10-07 2021-04-07 Sara Pellegrino POLYETHYLENIMMIN WITH N-ACYLATE HYDROXYPYRIDONIC FUNCTION, THEIR SYNTHESIS AND THERAPEUTIC USE
WO2022066110A1 (en) * 2020-09-25 2022-03-31 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising mesalamin and relevant excipients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (en) * 1990-04-17 1994-11-18 Eurand Int METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON
CA2082156A1 (en) * 1990-05-04 1991-11-05 Amnon Sintov Colonic drug delivery system
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
JPH07223970A (en) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd Releasing formulation at niche in digestive tract
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
KR100388569B1 (en) * 1994-04-22 2003-10-11 야마노우치세이야쿠 가부시키가이샤 Colon specific drug release oral pharmaceutical preparations

Also Published As

Publication number Publication date
WO1998026767A2 (en) 1998-06-25
WO1998026767A3 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
AU5775398A (en) Site-specific controlled release dosage formulation for mesalamine
AU1025297A (en) A controlled release formulation for poorly soluble basic drugs
AU6196394A (en) Controlled release formulation
AU1640097A (en) Extended release formulation
AU1806895A (en) Controlled release composition
AU3406497A (en) Controlled release tablet
AU2746992A (en) Controlled release pharmaceutical compositions
AU3854295A (en) Sustained release caffeine formulation
AU4256996A (en) Parasiticide formulations suitable for dermal application
AU3977099A (en) Controlled release oral dosage form
EG23934A (en) Poroxetine controlled release compositions
GB9826662D0 (en) Controlled release formulation
AU5200098A (en) Sustained release formulation containing dfmo
AU3066995A (en) Anion releasing apparatus for video appliances
AU3352297A (en) Controlled release tablets
AU4233997A (en) Process for preparing pharmaceutical compounds
AU4552797A (en) Spacing device for spreading stamped material
AU2160095A (en) Quick release receptacle
GB9404544D0 (en) Controlled release formulation
AU3749595A (en) Method for preparing controlled release pharmaceutical forms
AU3333997A (en) Device for eliminating deviation
AU7799198A (en) Method for preparing pharmaceutical formulation
AUPM457394A0 (en) Controlled release device
AU2003259586B9 (en) Extended release formulation
AU7055296A (en) Insecticide distribution means